Bellevue Pharmacy Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bellevue Pharmacy's estimated annual revenue is currently $10.5M per year.(i)
  • Bellevue Pharmacy's estimated revenue per employee is $201,000

Employee Data

  • Bellevue Pharmacy has 52 Employees.(i)
  • Bellevue Pharmacy grew their employee count by -4% last year.

Bellevue Pharmacy's People

NameTitleEmail/Phone
1
Business ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2591.1M80577%N/AN/A
#2
$13.1M655%N/AN/A
#3
$9.6M48-29%N/AN/A
#4
$12.5M629%N/AN/A
#5
$43.8M2184%N/AN/A
#6
$1.8M1864%N/AN/A
#7
$6.6M33-3%N/AN/A
#8
$11.7M5812%N/AN/A
#9
$1104.4M34340%$97MN/A
#10
$21.3M1067%N/AN/A
Add Company

What Is Bellevue Pharmacy?

As one of the country’s largest specialty pharmacies, Bellevue Pharmacy knows how important whole picture, whole patient solutions are for physicians and pharmacists. This is why we put the individual at the heart of everything we do – from individualized patient service, to patient and physician support. We believe when we get personal, people get better. With state-of-the-art facilities and a commitment to collaboration and support, Bellevue Pharmacy provides start-to-finish individualized solutions starting with the Power of Personal™. With over 250 years of combined experience in specialized medicine and top-notch standards, Bellevue Pharmacy offers unparalleled patient care and treatment solutions. We are proud of our Pharmacy Compounding Accreditation Board [PCAB] certification coupled with our distinction as a Center of Excellence by DynaLabs – one of only 18 pharmacies nationwide that holds this dual distinction. Bellevue Pharmacy is headquartered in St. Louis, Missouri.

keywords:N/A

N/A

Total Funding

52

Number of Employees

$10.5M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.8M562%N/A
#2
$7.5M576%N/A
#3
$6.4M5951%N/A
#4
$6.4M5951%N/A
#5
$19.1M607%N/A